FDA Inspection
Laboratorios Grifols, S.A.Laboratorios Grifols, S.A. – FDA Inspection, Sep 8, 2017
Record Details
This FDA Inspection record concerns Laboratorios Grifols, S.A., with an inspection on September 8, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Christophe T. Peters (Issuing Officer)
- Kellia N. Hicks (FDA Associated Person)
View Company Profile
ID · 1568ea7e-2615-4d79-992d-536a1d33b9e3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1025750
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Laboratorios Grifols, S.A.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 19, 2026 | Not classified | Office of Inspections and Investigations | |
| July 26, 2024 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 27, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 21, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Laboratorios Grifols, S.A.
- FDA Inspection 1325702 - 2026-06-19
- FDA Inspection 1244733 - 2024-07-26
- FDA Inspection 1268869 - 2023-10-27
- FDA Inspection 1123400 - 2019-09-20
- FDA Inspection 931864 - 2015-05-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.